Impact of physiological BM CD10+CD19+ B-cell precursors (haematogones) in the post-transplant period in patients with AML

被引：7

作者：

Christopeit, M. ^{[1
,2
]}

Heiland, A. ^{[3
]}

Binder, M. ^{[4
]}

Zabelina, T. ^{[3
]}

Ayuk, F. ^{[3
]}

Horn, C. ^{[4
]}

Haferlach, T. ^{[5
]}

Bokemeyer, C. ^{[4
]}

Kroeger, N. ^{[3
]}

Bacher, U. ^{[3
,5
]}

机构：

[1] Univ Hosp, Dept Internal Med Oncol & Haematol, Halle, Saale, Germany

[2] Med Fac Halle Saale, Halle, Saale, Germany

[3] UCCH, Dept Stem Cell Transplantat, Hamburg, Germany

[4] UCCH, Dept Internal Med 2, Hamburg, Germany

[5] MLL Munich Leukemia Lab, Munich, Germany

来源：

BONE MARROW TRANSPLANTATION | 2013年 / 48卷 / 09期

关键词：

MINIMAL RESIDUAL DISEASE; ALLO-SCT; CYTOMORPHOLOGY; RELAPSE;

D O I：

10.1038/bmt.2013.34

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：1257 / 1259

页数：3

共 10 条

[1] Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation [J].

Bacher, Ulrike ;

Badbaran, Anita ;

Fehse, Boris ;

Zabelina, Tatjana ;

Zander, Axel Rolf ;

Kroeger, Nicolaus .

EXPERIMENTAL HEMATOLOGY, 2009, 37 (01) :135-142

[2] Hematogones: a new prognostic factor for acute myeloblastic leukemia [J].

Chantepie, Sylvain P. ;

Salauen, Veronique ;

Parienti, Jean-Jacques ;

Truquet, Florence ;

Macro, Margaret ;

Cheze, Stephane ;

Vilque, Jean Pierre ;

Reman, Oumedaly .

BLOOD, 2011, 117 (04) :1315-1318

[3] Evaluation of BM cytomorphology after allo-SCT in patients with MDS [J].

Christopeit, M. ;

Ocheni, S. ;

Haferlach, T. ;

Miersch, K. ;

Zabelina, T. ;

Klyuchnikov, E. ;

Binder, M. ;

Ayuk, F. ;

Schafhausen, P. ;

Zander, A. R. ;

Bokemeyer, C. ;

Kroeger, N. ;

Bacher, U. .

BONE MARROW TRANSPLANTATION, 2013, 48 (03) :465-466

[4] Evaluation of BM cytomorphology after allo-SCT in patients with AML [J].

Christopeit, M. ;

Miersch, K. ;

Klyuchnikov, E. ;

Haferlach, T. ;

Binder, M. ;

Zabelina, T. ;

Ayuk, F. ;

Schafhausen, P. ;

Zander, A. R. ;

Bokemeyer, C. ;

Kroeger, N. ;

Bacher, U. .

BONE MARROW TRANSPLANTATION, 2012, 47 (12) :1538-1544

[5] Rituximab reduces the incidence of acute graft-versus-host disease [J].

Christopeit, Maximilian ;

Schuettee, Vincent ;

Theurich, Sebastian ;

Weber, Thomas ;

Grothe, Wilfried ;

Behre, Gerhard .

BLOOD, 2009, 113 (13) :3130-3131

[6] Impact of Bone Marrow Hematogones on Umbilical Cord Blood Transplantation Outcomes in Patients with Acute Myeloid Leukemia [J].

Honebrink, Theodore ;

Dayton, Vanessa ;

Burke, Michael J. ;

Larsen, Karen ;

Cao, Qing ;

Brunstein, Claudio ;

Weisdorf, Daniel ;

Miller, Jeffery S. ;

Wagner, John E. ;

Verneris, Michael R. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (06) :930-936

[7] Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia [J].

Kern, W ;

Voskova, D ;

Schoch, C ;

Hiddemann, W ;

Schnittger, S ;

Haferlach, T .

BLOOD, 2004, 104 (10) :3078-3085

[8] Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial [J].

Platzbecker, U. ;

Wermke, M. ;

Radke, J. ;

Oelschlaegel, U. ;

Seltmann, F. ;

Kiani, A. ;

Klut, I-M ;

Knoth, H. ;

Roellig, C. ;

Schetelig, J. ;

Mohr, B. ;

Graehlert, X. ;

Ehninger, G. ;

Bornhaeuser, M. ;

Thiede, C. .

LEUKEMIA, 2012, 26 (03) :381-389

[9] Quantitation of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic hematopoietic stem cell transplantation [J].

Shima, Takahiro ;

Miyamoto, Toshihiro ;

Kikushige, Yoshikane ;

Mori, Yasuo ;

Kamezaki, Kenjiro ;

Takase, Ken ;

Henzan, Hideho ;

Numata, Akihiko ;

Ito, Yoshikiyo ;

Takenaka, Katsuto ;

Iwasaki, Hiromi ;

Kamimura, Tomohiko ;

Eto, Tetsuya ;

Nagafuji, Koji ;

Teshima, Takanori ;

Kato, Koji ;

Akashi, Koichi .

BLOOD, 2013, 121 (05) :840-848

[10] Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation [J].

Yan, Chen-Hua ;

Liu, Dai-Hong ;

Liu, Kai-Yan ;

Xu, Lan-Ping ;

Liu, Yan-Rong ;

Chen, Huan ;

Han, Wei ;

Wang, Yu ;

Qin, Ya-Zhen ;

Huang, Xiao-Jun .

BLOOD, 2012, 119 (14) :3256-3262

← 1 →